ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Arno Therapeutics Inc (CE)

Arno Therapeutics Inc (CE) (ARNI)

0.0001
0.00
(0.00%)
Closed January 27 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.0001
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000058 52 Week Range 0.0003
Previous Close
0.0001
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
800
Financial Volume
-
VWAP
-

ARNI Latest News

Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief...

FLEMINGTON, N.J., July 18, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

FLEMINGTON, N.J., May 29, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Reports First Quarter 2014 Financial and Business Update

FLEMINGTON, N.J., May 15, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men's and Women's Cancers at 2014 ASCO Annual Meet...

Studies to determine recommended Phase II dose and safety profile of lead compound Will analyze relationship of biomarker to any anti-tumor activity observed FLEMINGTON, N.J., May 14, 2014...

Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual Meeting

FLEMINGTON, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistan...

FLEMINGTON, N.J., April 7, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational Milestones

FLEMINGTON, N.J., April 1, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present Three New Studies Supporting the Clinical Development of Onapristone at AACR Annual Meeting 2014...

FLEMINGTON, N.J., March 26, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Board of Directors Appoints Randy Thurman as Vice Chairman

FLEMINGTON, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present at 26th Annual ROTH Conference

FLEMINGTON, N.J., March 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
12000.00010.00010.00018000.0001CS
26-0.0002-66.66666666670.00030.00030.000174920.0001CS
524.2E-572.41379310345.8E-50.00035.8E-537570.00012027CS
156-0.002-95.23809523810.00210.00211.0E-665097.433E-5CS
260-0.0016-94.11764705880.00170.0421.0E-6644990.00498007CS

ARNI - Frequently Asked Questions (FAQ)

What is the current Arno Therapeutics (CE) share price?
The current share price of Arno Therapeutics (CE) is $ 0.0001
What is the 1 year trading range for Arno Therapeutics (CE) share price?
Arno Therapeutics (CE) has traded in the range of $ 0.000058 to $ 0.0003 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TGICTriad Guaranty Inc (CE)
$ 0.05
(49,900.00%)
1.4k
NOUVNouveau Life Pharmaceuticals Inc (PK)
$ 0.0002
(19,900.00%)
4.31M
ATYGAtlas Technology Group Inc (PK)
$ 0.0002
(19,900.00%)
9k
JFTHJapan Food Tech Holdings Inc (CE)
$ 0.0002
(19,900.00%)
255
ONCIOn4 Communications Inc (PK)
$ 0.0001
(9,900.00%)
16.82M
SPECSpectaire Holdings Inc (CE)
$ 0.000001
(-99.95%)
1.99k
TMPOQTempo Automation Holdings Inc (CE)
$ 0.000001
(-99.89%)
452
FUVVArcimoto Inc (CE)
$ 0.000001
(-99.50%)
336
SAFSSafer Shot Inc (CE)
$ 0.000001
(-99.00%)
2M
JAMNJammin Java Corp (PK)
$ 0.000001
(-99.00%)
39k
TKMOTekumo Inc (PK)
$ 0.0004
(0.00%)
244.5M
HMBLHUMBL Inc (PK)
$ 0.00075
(-6.25%)
219.57M
PDGOParadigm Oil and Gas Inc (PK)
$ 0.0002
(33.33%)
215.18M
GRLFGreen Leaf Innovations Inc (PK)
$ 0.000001
(-99.00%)
195.11M
DPLSDarkPulse Inc (PK)
$ 0.0006
(-14.29%)
182.43M

Discussion

View Full Feed
Jetmek_03052 Jetmek_03052 23 seconds ago
Hahahaha!

You’ve been touting a dime here for over THREE YEARS!!

Dream on.
DBMM
meds4life meds4life 24 seconds ago
Mine are mainly in my Roth but some bux freed up in my taxable - so I own some more...a nibble, a smear.
AVXL
HokieHead HokieHead 57 seconds ago
TWOH longs are good. Whenever this opens we are looking at a 5-10 bagger from the halt PPS. Not good for the TWOH naked shorts. Thanks for the concerns. Lmao.
TWOH
Fully Diluted Fully Diluted 2 minutes ago
Hi jog49,

I hold my shares. I repeat: I.hold.my.shares! 💯

GLTY 👍️
FNMA
ORCA ORCA 2 minutes ago
I AM NOT BUYING CRAP.YOU GUYS WILL BE BUYING,NOT ME.GOOD LUCK.
VDRM
Acme Investments Acme Investments 3 minutes ago
So I took a look at your previous responses and I didn't see anything on the TKMO board!! I've been following this stock when it had a very low SS!! Didn't see you anywhere around so maybe you're not aware of the constant dilution!! Not too long ago it was trading at .0009!!
TKMO
m0n m0n 3 minutes ago
style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: Arial, sans-serif; font-size: 15px; background-color: rgba(255, 255, 255, 1)"Actually it's not. $TWOH LoL. Ya just can't fix stupid. LoL
style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-
TWOH
ArcCeliaSkye ArcCeliaSkye 3 minutes ago
Laxmi Mail few days ago

We are progressing quite well in India and I am planning to fly back to HK in the early hours of 2nd of Feb - I am expecting Bank's KYC to complete on us and we will have accounts setup.

Before taking off here is my scheduled working in India --
ITUP
Ricorich Ricorich 4 minutes ago
I got confused for another AIG company about AIG's been a multi billion company.
I'm sorry for the confusion. Wrong info.
AIG
TenKay TenKay 4 minutes ago
Na…just amused you follow me around.

I must be living in your head rent free…

…oh yeah, almost forgot…

LOL.
MULN
JJ8 JJ8 5 minutes ago
Added AMD at $113.15 per share. GLTA
AMD
Fully Diluted Fully Diluted 5 minutes ago
Of course I think so, Clark,

that's what Bessent said. Well, he didn't explicitly mention Ackman. But look for yourself:

„ Question 71: Should the Trump Administration bar any individuals or entities who would financially profit from the end of Fannie and Freddie’s cons
FNMA
ArcCeliaSkye ArcCeliaSkye 6 minutes ago
Laxmi is again not responding on official or non official mail id
Neither on work nor on payments from last 3/4 months i have not recieved single penny

What kind of company you're running ???

There is no work ,no laptop provided nothing and sending some foolish
ITUP
PickStocks PickStocks 7 minutes ago
Tell everyone again how you bought in single digits and sold at 50.50 and coop no longer matter.....now you are referencing OG which you claimed to be one..the story keeps getting bigger every time you tell it......every post you make is how you bought in single digits and sold in the 50's like you
COOP
kund kund 7 minutes ago
Even without trial data SAVA was trading between 1.3-1.4 b, compare that with anavex, it was trading between 300mil-500mil. Imagine SAVA with trial data and EMA filing, it would have been trading close to $150. Market simply don’t t care anavex due to its ceo.
AVXL
k9narc k9narc 8 minutes ago
The bird flu was around during the presidential campaign.

donald dumbfuck said he'd lower the price of eggs.

How's that working so far.?
janice shell janice shell 8 minutes ago
We could move to Australia to get a better view...
igotthemojo igotthemojo 9 minutes ago
"and I would like to see Q4 sales numbers"

what for?...this company is toast...the pps was in the $30's when nkla said they wanted to r/s...it was in the $10 range when they actually did the r/s in late June....the pps now is 88 cents...

in 7 months, this company just r
NKLA
Dabeav Dabeav 9 minutes ago
3.50 near you soon! Same old broken record every fkn time somebody farts! 10 by Friday has gone to 10 within the next 10 yrs! But nice run up for the short haul! Back down they go.
FNMA
gitreal gitreal 9 minutes ago
Most inexperienced CEOs would’ve started running gold in the mill months ago, but not Jared he is optimizing it to the highest level for the future.

Maybe the lack of permits might have been a factor?
Maybe?

Why do you lie so much?
NBRI

Your Recent History

Delayed Upgrade Clock